Patients' Perceptions of Research Biopsies in Phase I Oncology Trials

Publisher： Karger

E-ISSN： 1423-0232|88|2|95-102

ISSN： 0030-2414

Source： Oncology, Vol.88, Iss.2, 2014-10, pp. : 95-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Study of Weekly Gemcitabine and Docetaxel in Patients with Advanced Cancer: A Hoosier Oncology Group Study

By  

Oncology, Vol. 62, Iss. 4, 2002-07 ,pp. : 299-304

Karger

Access to resources Recommend Favorite

Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti‐angiogenic therapy: A report from the children's oncology group phase I consortium

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 1, 2015-01 ,pp. : 45-51

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Predictive Markers in Oncology: Are Phase 3 Trials Always Required?

By  

Oncology, Vol. 81, Iss. 1, 2011-09 ,pp. : 1-2

Karger

Access to resources Recommend Favorite

Clinical Benefit for Patients with Non-Small Cell Lung Cancer Enrolled in Phase I Trials

By  

Oncology Research and Treatment, Vol. 36, Iss. 6, 2013-05 ,pp. : 357-362

Karger

Access to resources Recommend Favorite

Clinical Benefit of New Targeted Agents in Phase I Trials in Patients with Advanced Colorectal Cancer

By  

Oncology, Vol. 76, Iss. 3, 2009-01 ,pp. : 151-156

Karger

Access to resources Recommend Favorite